Moreover, the low levels of all three BCAAs may be due to a decrease in BCAA transaminase 1 (BCAT1) expression/activity, consistently, again, with lower mTORC1 activation in 59-2-HI tumours [65]. This evidence concerns the gene BCAT1 and neoplasm.